Maqueling, Armando M.

HRN: 19-26-62  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/06/2023
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
10/06/2023
10/12/2023
IVTT
1.5 G
Q8
Cap-MR
Waiting Final Action 
10/08/2023
CLARITHROMYCIN 500MG (CAP)
10/08/2023
10/15/2023
PO
500mg
BID
CAP MR
Waiting Final Action 
10/15/2023
CEFTAZIDIME 1GM (VIAL)
10/15/2023
10/21/2023
IV
1 Gram
Q8
CAP
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

 Indication:

              

 Type of Infection:

                             

           

 Compliance to guidelines:



 Initial appropriateness:



 If inappropriate:

           

 Final appropriateness:



 If inappropriate:

              

 Overall appropriateness: